PrimeVax Immuno-Oncology
PrimeVax Immuno-Oncology is a biotechnology company developing one-time one-week cancer treatments.
All edits by Michael Mangus
Edits on 18 Nov, 2020
Michael Mangus
Edits made to:
Timeline (+1 events) (+211 characters)
Timeline
January 22, 2019
PrimeVax Immuno-Oncology, Inc. announced an exclusive, worldwide license with the US Army Medical Materials Development Activity authorizing PrimeVax to use dengue virus-1 #45AZ5 strain for treatment of cancer
Find more companies like PrimeVax Immuno-Oncology
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.